Endo International PLC (NASDAQ:ENDP) – Stock analysts at Gabelli decreased their FY2017 earnings estimates for shares of Endo International PLC in a research report issued to clients and investors on Wednesday. Gabelli analyst K. Kedra now forecasts that the brokerage will post earnings of $4.20 per share for the year, down from their prior estimate of $4.80. Gabelli also issued estimates for Endo International PLC’s FY2018 earnings at $4.35 EPS.

ENDP has been the topic of several other research reports. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $40.00 price target on shares of Endo International PLC in a report on Tuesday, July 26th. Leerink Swann reissued a “market perform” rating and issued a $22.00 target price on shares of Endo International PLC in a research note on Friday, September 23rd. Piper Jaffray Cos. set a $19.00 target price on Endo International PLC and gave the company a “hold” rating in a research note on Tuesday, August 9th. Morgan Stanley set a $16.00 target price on Endo International PLC and gave the company a “hold” rating in a research note on Thursday, September 8th. Finally, Vetr raised Endo International PLC from a “hold” rating to a “buy” rating and set a $21.95 target price on the stock in a research note on Thursday, August 25th. One analyst has rated the stock with a sell rating, nine have given a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. Endo International PLC has an average rating of “Buy” and a consensus price target of $33.52.

Earnings History and Estimates for Endo International PLC (NASDAQ:ENDP)

Endo International PLC (NASDAQ:ENDP) last issued its quarterly earnings results on Tuesday, November 8th. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.81 by $0.20. Endo International PLC had a positive return on equity of 15.95% and a negative net margin of 3.32%. The company earned $894.30 million during the quarter, compared to analyst estimates of $862.47 million. During the same period in the previous year, the company earned $1.02 earnings per share. The company’s quarterly revenue was up 18.6% compared to the same quarter last year.

A number of hedge funds and other institutional investors have recently modified their holdings of ENDP. State Street Corp raised its position in shares of Endo International PLC by 9.3% in the second quarter. State Street Corp now owns 9,430,866 shares of the company’s stock worth $147,021,000 after buying an additional 805,101 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Endo International PLC by 0.9% in the first quarter. Geode Capital Management LLC now owns 1,759,167 shares of the company’s stock worth $49,422,000 after buying an additional 15,173 shares in the last quarter. RS Investment Management Co. LLC raised its position in shares of Endo International PLC by 0.4% in the second quarter. RS Investment Management Co. LLC now owns 1,374,185 shares of the company’s stock worth $21,424,000 after buying an additional 6,132 shares in the last quarter. Heartland Advisors Inc. purchased a new position in shares of Endo International PLC during the second quarter worth approximately $15,627,000. Finally, TIAA CREF Investment Management LLC raised its position in shares of Endo International PLC by 27.4% in the third quarter. TIAA CREF Investment Management LLC now owns 955,182 shares of the company’s stock worth $19,247,000 after buying an additional 205,522 shares in the last quarter. 96.61% of the stock is currently owned by hedge funds and other institutional investors.

Endo International PLC Company Profile

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

5 Day Chart for NASDAQ:ENDP

Receive News & Stock Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related stocks with our FREE daily email newsletter.